These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
526 related articles for article (PubMed ID: 26541778)
21. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
22. ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment. Luo H; England CG; Goel S; Graves SA; Ai F; Liu B; Theuer CP; Wong HC; Nickles RJ; Cai W Mol Pharm; 2017 May; 14(5):1646-1655. PubMed ID: 28292180 [TBL] [Abstract][Full Text] [Related]
23. PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging. Hong H; Yan Y; Shi S; Graves SA; Krasteva LK; Nickles RJ; Yang M; Cai W Mol Pharm; 2015 Feb; 12(2):403-10. PubMed ID: 25581441 [TBL] [Abstract][Full Text] [Related]
24. Noninvasive Detection of HER2 Expression in Gastric Cancer by Guo X; Zhu H; Zhou N; Chen Z; Liu T; Liu F; Xu X; Jin H; Shen L; Gao J; Yang Z Mol Pharm; 2018 Nov; 15(11):5174-5182. PubMed ID: 30251865 [TBL] [Abstract][Full Text] [Related]
25. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379 [TBL] [Abstract][Full Text] [Related]
26. Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model. Lane SR; Nanda P; Rold TL; Sieckman GL; Figueroa SD; Hoffman TJ; Jurisson SS; Smith CJ Nucl Med Biol; 2010 Oct; 37(7):751-61. PubMed ID: 20870150 [TBL] [Abstract][Full Text] [Related]
27. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer. Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842 [TBL] [Abstract][Full Text] [Related]
28. Targeting Phosphatidylserine with a Perreault A; Richter S; Bergman C; Wuest M; Wuest F Mol Pharm; 2016 Oct; 13(10):3564-3577. PubMed ID: 27608290 [TBL] [Abstract][Full Text] [Related]
29. Tumor and organ uptake of (64)Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies. Lee JH; Kim H; Yao Z; Lee SJ; Szajek LP; Grasso L; Pastan I; Paik CH Nucl Med Biol; 2015 Nov; 42(11):880-6. PubMed ID: 26307499 [TBL] [Abstract][Full Text] [Related]
31. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments. Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837 [TBL] [Abstract][Full Text] [Related]
32. Noninvasive Evaluation of CD20 Expression Using Kang L; Li C; Rosenkrans ZT; Engle JW; Wang R; Jiang D; Xu X; Cai W J Nucl Med; 2021 Mar; 62(3):372-378. PubMed ID: 32826320 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and comparative evaluation of novel (64)Cu-labeled high affinity cell-specific peptides for positron emission tomography imaging of tumor vasculature. Merrill JR; Krajewski K; Yuan H; Frank JE; Lalush DS; Patterson C; Veleva AN Biomaterials; 2016 Apr; 84():241-249. PubMed ID: 26839954 [TBL] [Abstract][Full Text] [Related]
34. Development of Woo SK; Jang SJ; Seo MJ; Park JH; Kim BS; Kim EJ; Lee YJ; Lee TS; An GI; Song IH; Seo Y; Kim KI; Kang JH J Nucl Med; 2019 Jan; 60(1):26-33. PubMed ID: 29777007 [TBL] [Abstract][Full Text] [Related]
35. Quantitative PET imaging of VEGF receptor expression. Chen K; Cai W; Li ZB; Wang H; Chen X Mol Imaging Biol; 2009; 11(1):15-22. PubMed ID: 18784964 [TBL] [Abstract][Full Text] [Related]
36. Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants. Meyer JP; Edwards KJ; Kozlowski P; Backer MV; Backer JM; Lewis JS J Nucl Med; 2016 Nov; 57(11):1811-1816. PubMed ID: 27390161 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of Fonseca Cabrera GO; Ma X; Lin W; Zhang T; Zhao W; Pan L; Li X; Barnhart TE; Aluicio-Sarduy E; Deng H; Wu X; Rakesh KP; Li Z; Engle JW; Wu Z J Nucl Med; 2024 Aug; 65(8):1250-1256. PubMed ID: 38871388 [TBL] [Abstract][Full Text] [Related]
39. Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab. Zhang Y; Hong H; Engle JW; Yang Y; Barnhart TE; Cai W Am J Nucl Med Mol Imaging; 2012 Jan; 2(1):1-13. PubMed ID: 22229128 [TBL] [Abstract][Full Text] [Related]
40. PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen. Elsässer-Beile U; Reischl G; Wiehr S; Bühler P; Wolf P; Alt K; Shively J; Judenhofer MS; Machulla HJ; Pichler BJ J Nucl Med; 2009 Apr; 50(4):606-11. PubMed ID: 19289418 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]